Articles, Op-Eds, & Blogs

June 8, 2020
Companies that rely on advertising revenue or other business models involving user data already pay taxes on their profits. Taxing them a second time for the data they collect doesn’t make sense, and it would unbalance the Internet ecosystem and put a price on many of the free services consumers currently enjoy.
June 8, 2020
Lawmakers have taken several positive steps in recent years to balance the benefits of data collection with the need to protect privacy and civil liberties. That should continue.
June 5, 2020
Travel restrictions due to COVID-19 are already putting severe pressure on international student recruitment. Eliminating Optional Practical Training (OPT) would make the problem much worse.
June 4, 2020
Writing for the World Economic Forum (WEF), Nigel Cory and WEF Digital Trade Fellow Mike Gallaher, summarize a recent report they authored for WEF that enumerates key steps policymakers should take to support cross-border payments and digital trade growth.
June 4, 2020
Big Internet, like other advanced industries like Big Auto, Big Aerospace, and Big Pharma, plays a key role in driving U.S. competitiveness, innovation, job creation, and economic growth. As such, policymakers should be careful to not cripple this engine of U.S. prosperity.
June 4, 2020
Just because DSTs may be attractive to individual countries doesn’t make them good policy. In fact, they are bad policy. A central goal of good tax policy should be to treat similar transactions the same way. DSTs violate this principle in a number of ways.
June 3, 2020
Trump should be careful of what he asks for because striking down Section 230 could very well have the opposite effect of what he intends.
June 1, 2020
AI-related publications increased 10 percent annually from 2005 to 2015, growing to 23 percent a year from 2015 to 2018.
May 27, 2020
As long as the Wall Street triumphalists’ unreflected “why worry?” thinking remains the norm, the urgently needed pursuit of a U.S. economic reform agenda will go nowhere.
May 27, 2020
In contrast to what critics might assert, now is not the time to undermine either the IP rights or reasonable pricing reimbursement approaches that have underpinned so much successful biomedical innovation, and which will be key to getting through this crisis.

Pages